DSE : ORIONPHARM

Orion Pharma Limited — Financial statements

Bangladesh

Last price 28.3 BDT (At close: Oct 29, 2026) · Market cap 6.62B

Latest research: Orion Pharma financial analysis: power revenue down 88%, BDT 25.6bn debt and a qualified audit (Oct 2026) · Orion Pharma: power revenue fell 88% after the plant contracts expired, leaving a BDT 25.6bn debt load on a pharma business earning BDT 251m

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Financial statements

Orion Pharma Limited (ORIONPHARM) reported revenue of 3.01B BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue3.01B4.08B10.62B13.93B9.66B10.83B
Cost of Revenue1.92B2.71B8.35B11.65B7.69B8.20B
Gross Profit1.09B1.38B2.27B2.27B1.97B2.63B
Selling, General & Admin1.23B1.32B1.34B1.28B1.29B1.14B
Other Operating Expenses-41.70M
Operating Expenses1.23B1.32B1.34B1.28B1.29B1.10B
Operating Income-134.87M55.90M929.02M992.96M675.12M1.54B
Interest Expense-432.95M-431.89M-393.38M-148.29M-173.23M-223.43M
Interest & Investment Income1.39M4.72M5.07M3.31M638.31M3.19M
Earnings From Equity Investments7.71M7.62M9.21M9.13M9.30M6.07M
Currency Exchange Gain (Loss)689.45K689.45K711.82K892.07K623.85K1.23M
Other Non Operating Income (Expenses)-2.76M-15.68M-14.75M-16.91M-86.74M-131.51M
EBT Excluding Unusual Items-560.80M-378.64M535.89M841.09M1.06B1.19B
Gain (Loss) on Sale of Investments-600.00-1.35K-2.86M207.75K78.11K-5.93M
Pretax Income-560.80M-378.64M533.03M841.30M1.06B1.19B
Income Tax Expense92.10M107.65M181.26M147.07M172.71M68.51M
Earnings From Continuing Operations-652.90M-486.30M351.77M694.23M890.75M1.12B
Minority Interest in Earnings57.60M71.02M-33.65M-53.29M-44.67M-185.68M
Net Income-595.30M-415.28M318.12M640.94M846.08M939.06M
Net Income to Common-595.30M-415.28M318.12M640.94M846.08M939.06M
Shares Outstanding (Basic)234.00M234.00M234.00M234.00M234.00M234.00M
Shares Outstanding (Diluted)234.00M234.00M234.00M234.00M234.00M234.00M
EPS (Basic)-2.54-1.771.362.743.624.01
EPS (Diluted)-2.54-1.771.362.743.624.01
Free Cash Flow400.80M336.97M-361.87M-1.37B-1.51B-1.69B
Free Cash Flow Per Share1.711.44-1.55-5.84-6.43-7.20
Dividend Per Share1.001.001.001.20
Gross Margin36.23%33.71%21.40%16.33%20.38%24.32%
Operating Margin-4.48%1.37%8.75%7.13%6.99%14.20%
Profit Margin-19.77%-10.17%3.00%4.60%8.76%8.67%
Free Cash Flow Margin13.31%8.25%-3.41%-9.81%-15.58%-15.56%
EBITDA411.29M673.35M1.50B1.57B1.15B2.53B
EBITDA Margin13.66%16.50%14.12%11.30%11.88%23.34%
D&A For EBITDA546.16M617.45M570.84M580.89M472.83M990.20M
EBIT-134.87M55.90M929.02M992.96M675.12M1.54B
EBIT Margin-4.48%1.37%8.75%7.13%6.99%14.20%
Effective Tax Rate34.01%17.48%16.24%5.74%
Advertising Expenses19.47M26.24M20.53M19.65M21.74M

Balance sheet

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents81.85M72.10M147.73M130.11M106.13M414.99M
Short-Term Investments66.49M54.18M45.82M38.68M31.83M23.62M
Cash & Short-Term Investments148.34M126.28M193.55M168.79M137.97M438.61M
Accounts Receivable4.37B4.39B4.21B5.58B6.80B3.94B
Other Receivables10.97B10.66B10.27B9.81B8.11B8.46B
Receivables15.35B15.05B14.48B15.39B14.91B12.40B
Inventory1.08B1.51B1.70B1.61B1.66B1.41B
Prepaid Expenses110.83K1.10M26.19M43.84M
Other Current Assets923.75M859.62M1.04B1.90B2.03B1.93B
Total Current Assets17.49B17.54B17.41B19.08B18.75B16.22B
Property, Plant & Equipment32.25B30.94B28.95B26.42B23.01B19.86B
Long-Term Investments7.40B7.32B8.07B7.44B6.34B6.25B
Other Long-Term Assets-1.00
Total Assets57.14B55.80B54.43B52.94B48.11B42.33B
Accounts Payable6.73B6.71B6.14B6.26B7.30B4.23B
Accrued Expenses278.75M278.28M298.44M270.03M265.44M232.48M
Short-Term Debt409.59M493.70M556.18M547.82M563.90M564.32M
Current Portion of Long-Term Debt67.35M490.50M387.47M274.33M
Current Portion of Leases14.02M14.93M13.94M23.91M31.66M36.42M
Current Income Taxes Payable334.88M321.16M304.49M435.26M398.62M262.75M
Other Current Liabilities733.59M645.99M390.05M1.44B488.23M406.06M
Total Current Liabilities8.50B8.46B7.77B9.47B9.44B6.01B
Long-Term Debt26.58B25.14B23.11B20.81B17.60B15.93B
Long-Term Leases32.16M31.69M13.71M26.35M35.27M39.90M
Long-Term Deferred Tax Liabilities453.26M402.12M315.43M157.70M122.25M138.28M
Other Long-Term Liabilities143.41M143.41M143.41M143.41M143.41M143.41M
Total Liabilities35.71B34.18B31.35B30.61B27.34B22.26B
Common Stock2.34B2.34B2.34B2.34B2.34B2.34B
Additional Paid-In Capital8.02B8.02B8.02B8.02B8.02B8.02B
Retained Earnings6.64B6.86B7.50B7.40B6.98B6.40B
Comprehensive Income & Other3.00B2.93B3.68B3.07B1.98B1.90B
Total Common Equity20.00B20.15B21.54B20.82B19.31B18.66B
Minority Interest1.43B1.47B1.54B1.51B1.46B1.41B
Shareholders' Equity21.43B21.62B23.08B22.33B20.77B20.07B
Total Liabilities & Equity57.14B55.80B54.43B52.94B48.11B42.33B
Total Debt27.04B25.68B23.76B21.90B18.62B16.84B
Net Cash (Debt)-26.88B-25.54B-23.55B-21.70B-18.45B-16.38B
Net Cash Per Share-114.86-109.14-100.65-92.74-78.83-69.99
Filing Date Shares Outstanding234.00M234.00M234.00M234.00M234.00M234.00M
Total Common Shares Outstanding234.00M234.00M234.00M234.00M234.00M234.00M
Working Capital9.00B9.07B9.65B9.61B9.32B10.22B
Book Value Per Share85.4686.0992.0588.9982.5379.76
Tangible Book Value20.00B20.15B21.54B20.82B19.31B18.66B
Tangible Book Value Per Share85.4686.0992.0588.9982.5379.76

Cash flow statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-595.30M-415.28M318.12M640.94M846.08M939.06M
Depreciation & Amortization576.04M634.40M588.70M601.12M498.45M1.02B
Loss (Gain) From Sale of Investments1.35K1.35K2.86M-207.75K-78.11K5.93M
Other Operating Activities412.30M425.53M432.84M256.66M-225.31M528.16M
Change in Accounts Receivable-86.15M-388.27M1.32B1.00B-2.84B-1.45B
Change in Inventory561.77M192.79M-96.04M45.45M-263.32M-133.11M
Change in Accounts Payable66.83M667.23M-1.13B-327.19M3.23B1.60B
Change in Other Net Operating Assets-113.69M-12.27M155.36M272.12M-79.30M77.52M
Operating Cash Flow821.80M1.10B1.59B2.49B1.16B2.59B
Capital Expenditures-421.00M-767.16M-1.95B-3.86B-2.67B-4.28B
Sale of Property, Plant & Equipment152.21M152.21M371.11M
Cash Acquisitions-61.81M-62.94M386.09M-1.38B-379.31M-1.63B
Investment in Securities-8.36M-8.36M-220.04K6.67K-8.60M28.67K
Other Investing Activities2.82M13.45M24.06M27.28M19.68M45.44M
Investing Cash Flow-336.14M-672.80M-1.17B-5.21B-3.04B-5.86B
Short-Term Debt Issued16.21M11.20M387.98M392.27M
Long-Term Debt Issued764.90M3.31B1.78B3.13B
Total Debt Issued240.03M781.11M3.32B2.17B3.52B
Short-Term Debt Repaid-62.48M
Long-Term Debt Repaid-281.23M-22.33M-28.36M-33.66M-40.63M
Lease Payments-16.98M-17.47M-22.33M-28.36M-33.66M-40.63M
Total Debt Repaid-581.03M-343.71M-22.33M-28.36M-33.66M-40.63M
Net Debt Issued (Repaid)-341.00M-343.71M758.78M3.29B2.14B3.48B
Common Dividends Paid-461.33K-8.21M-269.90M-152.94M-324.54M-340.17M
Dividends Paid-461.33K-8.21M-269.90M-152.94M-324.54M-340.17M
Other Financing Activities-135.89M-155.04M-890.42M-401.76M-249.56M-488.68M
Financing Cash Flow-477.35M-506.96M-401.55M2.74B1.56B2.65B
Miscellaneous Cash Flow Adjustments2.001.001.00-1.001.00-1.00
Net Cash Flow8.31M-75.63M17.62M23.97M-308.86M-619.18M
Free Cash Flow400.80M336.97M-361.87M-1.37B-1.51B-1.69B
Free Cash Flow Margin13.31%8.25%-3.41%-9.81%-15.58%-15.56%
Free Cash Flow Per Share1.711.44-1.55-5.84-6.43-7.20
Levered Free Cash Flow-545.25M269.21M-618.16M-3.07B-1.37B-36.58M
Unlevered Free Cash Flow-274.66M539.14M-372.30M-2.97B-1.26B103.06M
Free Cash Flow After Leases383.82M319.50M-384.20M-1.39B-1.54B-1.73B
Cash Interest Paid371.39M155.04M890.42M401.76M249.56M488.68M
Cash Income Tax Paid39.56M45.65M194.54M117.03M95.73M40.91M
Change in Working Capital428.76M459.48M244.04M994.67M42.63M99.74M

Ratios

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization6.62B7.09B16.17B18.63B20.59B12.61B
Enterprise Value34.93B32.16B39.76B42.35B40.51B28.90B
Last Close Price28.3030.3067.3676.6383.7450.68
PE Ratio50.8329.0624.3413.43
PS Ratio2.201.741.521.342.131.16
PB Ratio0.310.330.700.830.990.63
P/TBV Ratio0.330.350.750.891.070.68
P/FCF Ratio16.5221.04
P/OCF Ratio8.066.4210.197.4717.734.87
EV/Sales Ratio11.607.883.743.044.192.67
EV/EBITDA Ratio80.0947.7726.5126.9135.2911.43
EV/EBIT Ratio575.4242.8042.6560.0118.79
EV/FCF Ratio87.1695.45
Debt / Equity Ratio1.261.191.030.980.900.84
Debt / EBITDA Ratio63.1137.2015.6613.7415.876.59
Debt / FCF Ratio67.4676.20
Net Debt / Equity Ratio1.251.181.020.970.890.82
Net Debt / EBITDA Ratio65.3537.9315.7013.7916.076.48
Net Debt / FCF Ratio67.0675.79-65.08-15.88-12.26-9.72
Asset Turnover0.050.070.200.280.210.27
Inventory Turnover1.411.695.047.125.016.10
Quick Ratio1.821.791.891.641.592.14
Current Ratio2.062.072.242.011.992.70
Return on Equity (ROE)-2.98%-2.18%1.55%3.22%4.36%5.73%
Return on Assets (ROA)-0.15%0.06%1.08%1.23%0.93%2.43%
Return on Invested Capital (ROIC)-0.28%0.12%1.35%1.97%1.49%4.24%
Return on Capital Employed (ROCE)-0.30%0.10%2.00%2.30%1.70%4.20%
Earnings Yield-8.99%-5.86%1.97%3.44%4.11%7.45%
FCF Yield6.05%4.75%-2.24%-7.33%-7.31%-13.36%
Dividend Yield1.45%1.26%1.14%2.23%
Payout Ratio84.84%23.86%38.36%36.22%
Total Shareholder Return1.45%1.26%1.14%2.23%